Related references
Note: Only part of the references are listed.RAS proto-oncogene in medullary thyroid carcinoma
Margarida M. Moura et al.
ENDOCRINE-RELATED CANCER (2015)
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
Samuel A. Wells et al.
THYROID (2015)
Identification of Driving ALK Fusion Genes and Genomic Landscape of Medullary Thyroid Cancer
Jun Ho Ji et al.
PLOS GENETICS (2015)
Twenty years of lesson learning: how does the RET genetic screening test impact the clinical management of medullary thyroid cancer?
Cristina Romei et al.
CLINICAL ENDOCRINOLOGY (2015)
Identification of Novel Small Molecule Inhibitors of Oncogenic RET Kinase
Marialuisa Moccia et al.
PLOS ONE (2015)
BRAF V600E and TERT Promoter Mutations Cooperatively Identify the Most Aggressive Papillary Thyroid Cancer With Highest Recurrence
Mingzhao Xing et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
High-throughput mutation profiling improves diagnostic stratification of sporadic medullary thyroid carcinomas
Michele Simbolo et al.
VIRCHOWS ARCHIV (2014)
Multiple Endocrine Neoplasia Type 2 and Familial Medullary Thyroid Carcinoma: An Update
Samuel A. Wells et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Exomic Sequencing of Medullary Thyroid Cancer Reveals Dominant and Mutually Exclusive Oncogenic Mutations in RET and RAS
Nishant Agrawal et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Cabozantinib in Progressive Medullary Thyroid Cancer
Rossella Elisei et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Evidence of a Low Prevalence of RAS Mutations in a Large Medullary Thyroid Cancer Series
Raffaele Ciampi et al.
THYROID (2013)
Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
Samuel A. Wells et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Low Prevalence of the Somatic M918T RET Mutation in Micro-Medullary Thyroid Cancer
Cristina Romei et al.
THYROID (2012)
2012 European Thyroid Association Guidelines for Genetic Testing and Its Clinical Consequences in Medullary Thyroid Cancer
R. Elisei et al.
EUROPEAN THYROID JOURNAL (2012)
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC)
C. Romei et al.
CLINICAL ENDOCRINOLOGY (2011)
In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer
B. Cosci et al.
ENDOCRINE-RELATED CANCER (2011)
Combined RET and Ki-67 assessment in sporadic medullary thyroid carcinoma: a useful tool for patient risk stratification
Caterina Mian et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
The Effects of Four Different Tyrosine Kinase Inhibitors on Medullary and Papillary Thyroid Cancer Cells
Hans H. G. Verbeek et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
High Prevalence of RAS Mutations in RET-Negative Sporadic Medullary Thyroid Carcinomas
Margarida M. Moura et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Correlation of RET somatic mutations with clinicopathological features in sporadic medullary thyroid carcinomas
M. M. Moura et al.
BRITISH JOURNAL OF CANCER (2009)
RET oncogene in MEN2, MEN2B, MTC and other forms of thyroid cancer
Maya B. Lodish et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2008)
Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer:: A 10-year follow-up study
Rossella Elisei et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Somatic mutations affect key pathways in lung adenocarcinoma
Li Ding et al.
NATURE (2008)
Current approaches to medullary thyroid carcinoma, sporadic and familial
Elizabeth A. Fialkowski et al.
JOURNAL OF SURGICAL ONCOLOGY (2006)
RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors
Jan Willem B. de Groot et al.
ENDOCRINE REVIEWS (2006)
New multiple somatic mutations in the RET proto-oncogene associated with a sporadic medullary thyroid carcinoma
S Dvoráková et al.
THYROID (2006)
The finding of a somatic deletion in RET exon 15 clarified the sporadic nature of a medullary thyroid carcinoma suspected to be familial
J Oriola et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2002)
Share Paper
